Weed Inc
WEED, Inc., together with its subsidiaries, focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was incorporated in 1999 and is headquartered in Tucson, Arizona.
Weed Inc (BUDZ) - Net Assets
Latest net assets as of September 2025: $-519.08K USD
Based on the latest financial reports, Weed Inc (BUDZ) has net assets worth $-519.08K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($532.27K) and total liabilities ($1.05 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-519.08K |
| % of Total Assets | -97.52% |
| Annual Growth Rate | N/A |
| 5-Year Change | -125.07% |
| 10-Year Change | N/A |
| Growth Volatility | 260.45 |
Weed Inc - Net Assets Trend (2011–2024)
This chart illustrates how Weed Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Weed Inc (2011–2024)
The table below shows the annual net assets of Weed Inc from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-221.01K | -186.56% |
| 2023-12-31 | $255.31K | +50.36% |
| 2022-12-31 | $169.80K | -72.50% |
| 2021-12-31 | $617.50K | -29.97% |
| 2020-12-31 | $881.72K | -26.50% |
| 2019-12-31 | $1.20 Million | -56.56% |
| 2018-12-31 | $2.76 Million | +666.67% |
| 2017-12-31 | $360.21K | +231.69% |
| 2016-12-31 | $-273.53K | -26.87% |
| 2015-12-31 | $-215.60K | -99.83% |
| 2014-12-31 | $-107.89K | +2.67% |
| 2011-12-31 | $-110.85K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Weed Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7772218000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $84.68 Million | % |
| Total Equity | $-221.01K | 100.00% |
Weed Inc Competitors by Market Cap
The table below lists competitors of Weed Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MARKET VECTR RETAIL
BE:VEFW
|
$2.16 Million |
|
ACRUX Ltd
AU:ACR
|
$2.16 Million |
|
Globalink Investment Inc
NASDAQ:GLLI
|
$2.16 Million |
|
Argo Blockchain PLC
PINK:ARBKF
|
$2.16 Million |
|
HIKARI TSUSHIN
MU:HIK
|
$2.16 Million |
|
Norwood Systems Ltd
AU:NOR
|
$2.16 Million |
|
The Gold Bond Group Ltd
TA:GOLD
|
$2.16 Million |
|
Sambhaav Media Limited
NSE:SAMBHAAV
|
$2.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Weed Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 255,309 to -221,006, a change of -476,315 (-186.6%).
- Net loss of 510,716 reduced equity.
- Other factors increased equity by 34,401.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-510.72K | -231.09% |
| Other Changes | $34.40K | +15.57% |
| Total Change | $- | -186.56% |
Book Value vs Market Value Analysis
This analysis compares Weed Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | $0.00 | $0.03 | x |
| 2016-12-31 | $0.00 | $0.03 | x |
| 2017-12-31 | $0.00 | $0.03 | x |
| 2018-12-31 | $0.03 | $0.03 | x |
| 2019-12-31 | $0.01 | $0.03 | x |
| 2020-12-31 | $0.01 | $0.03 | x |
| 2021-12-31 | $0.01 | $0.03 | x |
| 2022-12-31 | $0.00 | $0.03 | x |
| 2023-12-31 | $0.00 | $0.03 | x |
| 2024-12-31 | $0.00 | $0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Weed Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-513.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.08 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.71 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.22 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.12 Million |
| 2017 | -966.63% | 0.00% | 0.00x | 3.63x | $-3.52 Million |
| 2018 | -1061.51% | 0.00% | 0.00x | 1.09x | $-29.59 Million |
| 2019 | -2294.82% | 0.00% | 0.00x | 1.63x | $-27.65 Million |
| 2020 | -461.04% | 0.00% | 0.00x | 2.06x | $-4.15 Million |
| 2021 | -460.22% | 0.00% | 0.00x | 3.17x | $-2.90 Million |
| 2022 | -899.97% | 0.00% | 0.00x | 9.62x | $-1.55 Million |
| 2023 | -12.36% | 0.00% | 0.00x | 3.54x | $-57.09K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-488.62K |
Industry Comparison
This section compares Weed Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Weed Inc (BUDZ) | $-519.08K | 0.00% | N/A | $2.16 Million |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |